Breast Implant Rupture — Symptoms, Imaging, and Revision

Every breast implant has an outer elastomer shell. With saline implants, that shell contains sterile salt water. With silicone implants, it contains cohesive silicone gel. Rupture refers to loss of shell integrity, whether the opening is a small fatigue tear at a fold or a more obvious defect. It is not the same as normal surface wrinkling, and it cannot be diagnosed from touch alone.

The body normally forms a layer of scar tissue, called a capsule, around an implant. If silicone leaves the shell but stays within this capsule, the finding is called an intracapsular rupture. If gel passes through the capsule into breast tissue or nearby lymphatic tissue, it is called an extracapsular rupture. That distinction matters because it changes what imaging shows and how extensive surgical cleanup may need to be.

Saline rupture is usually noticed because the affected breast deflates over hours or days, although the pace can vary. Silicone rupture is harder to recognize. Some patients notice increasing firmness, a contour change, tenderness, burning, numbness, swelling, or a new lump; many notice nothing. Symptoms can prompt assessment, but their absence does not establish that a silicone implant is intact.

Silent rupture describes a silicone shell failure that produces no reliable outward symptom. Modern cohesive gel can hold together, and the capsule can contain it, so breast size may remain stable. A patient may feel well and still have an imaging finding. Conversely, discomfort does not automatically mean rupture. This is why symptom checking and imaging answer different questions.

Regular follow-up imaging is intended to find changes that an examination cannot. Ultrasound is widely used as a practical first study, while MRI can be used when ultrasound is inconclusive, when suspicion remains, or when the clinical situation calls for more detailed mapping. A normal or non-diagnostic study is not a lifetime safety certificate: it describes what was detected at that examination. Our related breast implant ultrasound guide explains what a surveillance visit can and cannot show.

Shells can weaken with time and repeated mechanical loading. A persistent fold can concentrate stress along one line; severe capsular contracture can compress and distort the implant; an instrument can damage a shell during implantation or a later procedure; and substantial trauma may occasionally contribute. Manufacturing defects are another possible, but not automatically proven, explanation.

Often there is no single event to identify. Age, pocket mechanics, capsule behavior, implant design, and prior operations may overlap. Observational reports can reveal associations, but they do not prove that one factor caused an individual rupture. Ordinary exercise or a routine mammogram should not be blamed without diagnostic evidence, and a patient should always tell the imaging team that implants are present so appropriate views and technique can be used.

Risk generally becomes more relevant as an implant spends longer in the body, but there is no single expiration date at which every implant fails. Previous implant surgery, known capsular contracture, a history of significant chest trauma, a pocket that allows recurrent implant folding, or an implant already described as suspicious on imaging can justify closer assessment. The importance of each factor varies by patient and implant generation.

Not having symptoms, having a soft breast, or having passed an earlier scan does not make later rupture impossible. Likewise, an older implant does not have to be replaced solely because of its age if assessment is reassuring and there is no other indication. Surveillance and replacement decisions should be individualized rather than based on a universal anniversary.

No strategy can reduce the possibility to zero. During surgery, anatomy-matched implant selection, a pocket that does not force the shell into a sharp fold, careful handling, and protection from instrument contact are relevant technical considerations. After surgery, keeping implant records, attending follow-up, and arranging imaging when recommended make silent problems more likely to be recognized before they become extensive.

Patients should seek assessment after a meaningful contour change, new persistent swelling, a new breast or armpit lump, or unexplained pain rather than trying to test the implant by squeezing it. Prevention advice cannot guarantee shell integrity, and screening reduces uncertainty only for the time and limits of the test performed.

Assessment starts with the implant history: brand if known, fill type, placement plane, incision, operation date, prior revisions, and the timing of new changes. The clinician compares breast size, contour, firmness, fold position, skin, scars, and lymph-node areas. These findings help set the imaging question but cannot reliably exclude silent silicone rupture.

Ultrasound can examine the shell, gel, capsule, surrounding fluid, and visible lymph nodes in real time. It is often a reasonable first test for a symptomatic patient and can also be used in surveillance. MRI provides broader detail about silicone implant integrity and can clarify an indeterminate ultrasound. Mammography is important for breast screening when otherwise indicated, but it is not the primary test for confirming silicone shell integrity.

Imaging is interpreted with the clinical picture. False-positive, false-negative, and equivocal findings are possible. If symptoms and the report do not agree, review of the actual images, repeat targeted ultrasound, MRI, or interval follow-up may be appropriate. Non-detection is not proof of permanent safety.

Radiology reports use visual shorthand. The linguine sign on MRI means the collapsed implant shell appears as wavy lines floating within silicone gel, like strands of pasta. A stepladder appearance is the ultrasound counterpart: multiple short, roughly parallel bright lines suggest folds of a collapsed shell. These are signs the radiologist integrates with the full study, not words a patient should use to self-diagnose from one screenshot.

A keyhole or noose sign describes silicone extending into a shell fold while still contained by the surrounding capsule; in plain language, the scan raises concern for an intracapsular tear before free gel is mapped outside the capsule. A snowstorm appearance on ultrasound is a hazy, dirty shadow created when silicone is present in tissue beyond the implant. It can support extracapsular silicone, including in a lymph node, but other findings and the examination still matter.

The practical translation is simple: intracapsular means gel is outside the shell but held inside the capsule; extracapsular means it has traveled beyond that boundary. The latter may require a wider search and more extensive removal. The exact sign, certainty level, and location should be reviewed with a clinician experienced in implant imaging and revision planning.

Published rupture estimates differ because studies involve different products, implant ages, primary augmentation or reconstruction populations, follow-up completion, imaging schedules, and definitions. A study that routinely scans asymptomatic patients can detect more silent ruptures than a registry that counts only patients who present with symptoms. Numbers from separate core studies are not a head-to-head product ranking unless the methods and populations were designed for that comparison.

Adverse-event databases and manufacturer surveillance can add signals, but many reports are voluntary. Under-reporting, duplicate reports, missing implant details, publicity-driven reporting, and the lack of a known denominator mean these sources cannot establish incidence or prove causation by themselves. Few reports do not demonstrate safety, just as many reports do not by themselves establish an individual cause. Conclusions should match the limits of the data.

A confirmed ruptured implant is generally reviewed for surgical removal rather than left indefinitely. The plan may be removal alone, removal and replacement, or removal combined with reshaping such as a lift or, in selected cases, fat grafting. The decision depends on the patient's goals, tissue envelope, implant position, capsule, contamination by gel, and whether another implant remains appropriate.

For silicone rupture, the operation removes the implant and visible free gel. The capsule is assessed rather than automatically treated the same way in every patient. Capsulectomy may be partial or total when silicone has infiltrated the capsule, the capsule is abnormal, or access and safety favor removal. An intact total capsulectomy may sometimes contain the contents, but it is not always technically possible or safer; en bloc removal is a specific oncologic concept and is not a routine requirement for uncomplicated rupture.

With extracapsular silicone, the surgeon may need to remove accessible silicone granuloma or affected tissue while balancing completeness against injury to healthy structures. Replacement size, pocket plane, and fold support are reconsidered so the revision addresses the mechanical setting as well as the failed device. No operation can promise that every microscopic trace will be removed or that a future implant will never rupture.

The Korean source pathway describes many rupture revisions as taking about one to two hours under general anesthesia, with same-day discharge, suture review or removal around seven to ten days, and return to many daily activities in roughly one to two weeks. These are planning ranges, not promises. Extensive extracapsular cleanup, capsulectomy, a new pocket, a lift, other combined surgery, or an individual medical condition can lengthen recovery.

Early care may include a prescribed support garment, incision care, medication, limits on lifting and upper-body exercise, and scheduled review. Increasing one-sided swelling, spreading redness, fever, shortness of breath, severe pain, or a rapidly changing breast warrants prompt medical contact. Final contour takes longer than initial functional recovery because swelling, the pocket, and the tissues continue to settle.

For a patient considering travel to Gangnam for revision, the useful first step is a records-based review rather than choosing a procedure from a menu. Send the implant card or operative note if available, the written ultrasound or MRI report, accessible image files rather than screenshots alone, a symptom timeline, prior incision details, and current photographs taken according to clinic instructions. A remote review can frame possibilities, but the final diagnosis and plan require in-person examination and, when indicated, repeat imaging.

A consultation estimate should separate the components that actually apply: removal or exchange, the extent of capsule work, management of extracapsular silicone, creation or change of the pocket, implant choice, and any lift or limited fat grafting. It should also clarify anesthesia, facility care, pathology when needed, medications, garments, follow-up, and what is excluded. Umnagumo is a Gangnam clinic dedicated exclusively to breast surgery; that focus does not guarantee a particular result, and candidacy remains individual.

Travel planning should allow time for preoperative assessment, surgery only after the plan is confirmed, early postoperative checks, and clearance before flying. Patients should also arrange a clinician at home for later follow-up and understand how urgent concerns will be handled after departure. A lower quotation may not be the less costly pathway if it omits capsule work, imaging, or follow-up that the actual findings require.